Early market entry is often necessary to generate revenue and support the commercialisation of innovation. Jasdeep Singh, CEO of SingleTimeMicroneedles, explains how his company bridged the financing gap through navigating alternatives to traditional regulatory and go-to-market strategies.
Milestone - Regulatory Approval
Biopharma
Treatment
Prevention
Go-to-Market
Companion and Livestock
2025 Showcase Finalist

Jasdeep Singh
CEO
SingleTimeMicroneedles